Physician profile
Freya Marone
NPI 1649386145
$1,162.81
in general payments reported to CMS, 2019-2025
12 companies · $22.06 in 2025
The $22.06 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $151 · 2021: $216 · 2022: $148 · 2023: $110 · 2024: $241 · 2025: $22.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $267.66 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $261.68 | 2020-2024 | Tradjenta, Jardiance |
| Astrazeneca Pharmaceuticals LP | $252.92 | 2019-2024 | Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $133.29 | 2024 | |
| Cardiovascular Systems INC. | $78.04 | 2020 | |
| Lilly USA, LLC | $46.68 | 2023-2024 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $28.69 | 2023 | |
| Exact Sciences Corporation | $22.06 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $19.91 | 2024 | Veozah |
| Otsuka America Pharmaceutical, INC. | $19.30 | 2019 | |
| Phadia US INC. | $16.79 | 2019 | |
| Novo Nordisk INC | $15.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Freya Marone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.